Genetic alterations of DUX4 account for about 4–7% of B-ALL in pediatric cases and increase to more than 15% in adolescent and young adults (AYA) B-ALL [63,64,65]. The gene discussed is DUX4; the disease is acute lymphoblastic leukemia.